Novo Nordisk A S NVO
NYSE NVO
$38.63 +0.48 (+1.26%)
At close: Oct 9, 2026 · 4:00 PM EDT

Novo Nordisk A S (NVO) Liabilities and Shareholders Equity (2013 - 2015)

Updated

Novo Nordisk A S (NVO) recorded Liabilities and Shareholders Equity of $113.61 billion in FY2016, up 23.8% from $91.8 billion in FY2015.

Analysis

Novo Nordisk A S (NVO) Liabilities and Shareholders Equity (2013 - 2015) Analysis & Trends

Starting with FY2013, Novo Nordisk A S's Liabilities and Shareholders Equity history includes 4 years.

  • Annual Liabilities and Shareholders Equity has increased for three straight years, with a three-year compound annual growth rate of 17.3% (FY2013 to FY2016).
  • Per Business Quant data, NVO's Liabilities and Shareholders Equity was $91.8 billion in FY2015 (+19.1%), $77.06 billion in FY2014 (+9.6%) and $70.34 billion in FY2013.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 91.80 Bn
Dec 31, 2014 77.06 Bn
Dec 31, 2013 70.34 Bn
API Access

Novo Nordisk A S Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NVO&period=max&api_key=YOUR_API_KEY